COVID-19 and Pulmonary Arterial Hypertension: Early Data and Many Questions
نویسندگان
چکیده
منابع مشابه
THE EFFECTS OF CAPTOPRIL ON PULMONARY AND SYS TEMIC ARTERIAL PRESSURES IN HIGHALTITUDE PULMONARY HYPERTENSION
The purpose of this investigation was to assess the effect of captopril on both systemic (P.a) and pulmonary arterial pressures (PPA) in patients with high-altitude pulmonary hypertension (HAPH). Seventeen patients (mean age 44±6.8 years) with HAPH and mild to moderate systemic arterial hypertension were included in the study. All patients underwent right heart catheterization with measurem...
متن کاملNew answers raise new questions in pulmonary arterial hypertension.
Research and treatment of pulmonary vascular diseases pose distinct challenges. Despite these hurdles (or perhaps because of them), a cadre of basic scientists, geneticists, physiologists, clinical researchers and clinicians have dedicated themselves to the study and care of patients with pulmonary vascular disease. The European Respiratory Journal (ERJ) series "Advances in Pathobiology, Diagno...
متن کاملPrevalence and Risk Factors of Pulmonary Arterial Hypertension in Thalassemia Major Patients of Ilam, 2014
Pulmonary arterial hypertension (PAH) is a progressive disease with high morbidity and mortality rates. Research has shown that PAH has a prevalence rate of 10-79% in thalassemia major patients. This cross-sectional study was carried out in 2014 to determine the prevalence and risk factors of PAH in all thalassemia major patients of over 18 years of age in Ilam, Iran. A cardiologist measured sy...
متن کاملEarly detection and management of pulmonary arterial hypertension.
The long-term prognosis for patients with pulmonary arterial hypertension (PAH) remains poor, despite advances in treatment options that have been made in the past few decades. Recent evidence suggests that World Health Organization functional class I or II patients have significantly better long-term survival rates than patients in higher functional classes, thus providing a rationale for earl...
متن کاملlevamisole, aminorex, and pulmonary arterial hypertension: a review
conclusions the results of the first human pharmacokinetic studies of aminorex were first characterized in 2013. the results suggest that while humans could produce aminorex from levamisole, they probably do not convert very much. even though cases of pah have been reported in cocaine users, the latest pharmacokinetic studies suggest that very little aminorex is actually produced from the inges...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of the American Thoracic Society
سال: 2020
ISSN: 2329-6933,2325-6621
DOI: 10.1513/annalsats.202008-1014ed